[Controlled clinical experimentation of a new synthetic preparation (MY 41-6) with anti-inflammatory, antalgic and myorelaxant effect].
D000328:Adult; D000368:Aged; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007592:Joint Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000188:drug therapy; D009467:Neuromuscular Depolarizing Agents / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use; D011843:Radiculopathy / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D009467:Neuromuscular Depolarizing Agents; D010653:Phenylbutazone
Sperimentazione clinica controllata di un nuovo preparato di sintesi (MY 41-6) ad azione antiflogistica, antalgica, miorilassante.